I co-authored an article in Cancer Research entitled “Integration of Germline and Somatic Variation Improves Chronic Lymphocytic Leukemia Risk Stratification” led by Dr. Aubrey Hubbard. We investigated whether inclusion of a chronic lymphocytic leukemia (CLL)-associated polygenic score and two common types of clonal hematopoiesis (i.
I co-authored an article in the Journal of the National Cancer Institute entitled “Associations of self-identified race and ethnicity and genetic ancestry with mortality among cancer survivors” led by Dr. Jacqueline Vo and Dr.
I was a co-author on a poster entitled “Comparing the association of self-reported race-ethnicity and genetic ancestry with all-cause mortality: A pan-cancer survivor analysis in the PLCO Screening Trial” at the 14th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved by Dr.
I received a William G. Coleman Minority Health and Health Disparities Research Innovation Award from the National Institute on Minority Health and Health Disparities (NIMHD) for a joint research proposal entitled “HDoCS in PLCO: Health Disparities of Cancer Survivors in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.